Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetes.
Gault, Victor A
Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetes. [electronic resource] - Pancreas Jul 2007 - 73-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1536-4828
10.1097/mpa.0b013e31804fa19a doi
Animals
Blood Glucose--drug effects
Body Weight--drug effects
Diabetes Mellitus, Experimental--drug therapy
Eating--drug effects
Gastric Inhibitory Polypeptide--pharmacology
Glucagon--metabolism
Glucose Tolerance Test
Glycated Hemoglobin--metabolism
Homeostasis--drug effects
Insulin--blood
Islets of Langerhans--drug effects
Male
Mice
Somatostatin--metabolism
Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetes. [electronic resource] - Pancreas Jul 2007 - 73-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1536-4828
10.1097/mpa.0b013e31804fa19a doi
Animals
Blood Glucose--drug effects
Body Weight--drug effects
Diabetes Mellitus, Experimental--drug therapy
Eating--drug effects
Gastric Inhibitory Polypeptide--pharmacology
Glucagon--metabolism
Glucose Tolerance Test
Glycated Hemoglobin--metabolism
Homeostasis--drug effects
Insulin--blood
Islets of Langerhans--drug effects
Male
Mice
Somatostatin--metabolism